在蛋白质组中调解门德尔随机化,确定了与肥胖相关的过敏喘的潜在药物标
Jiannan Lin1, Shuwen Lu2, Xiaoyu Zhao2
1Department of Pediatrics, Jiaxing Second Hospital, Jiaxing, 314000, China. jiannanlin0129@126.com.
Hereditas
|February 1, 2025
概括
肥胖因果上会增加过敏喘的风险,因为它会影响像TPST1.1.这样的血蛋白. 这些蛋白质,包括TPST1,可能为治疗与肥胖相关的喘提供新的治疗点.
科学领域:
- 免疫学和遗传学
- 代谢障碍 代谢障碍 代谢障碍
- 呼吸系统医学 呼吸系统医学
背景情况:
- 全球肥胖率的上升与喘发病率的增加有关.
- 与肥胖相关的喘的潜在机制尚未完全理解.
- 目前针对肥胖相关喘的治疗方法的有效性有限.
研究的目的:
- 调查肥胖和过敏性喘之间的因果关系.
- 为了阐明与肥胖相关的喘的发病原因.
- 为潜在的临床干预确定调解这种关系的血蛋白.
主要方法:
- 调解 门德尔的随机化 (MR) 分析用于评估因果关系.
- 仪表变量 (IV) 被严格选择.
- 基因本体学 (GO) 和基因和基因组的京都百科全书 (KEGG) 的分析探索了介质蛋白的功能.
- 对药物向的MR分析评估了潜在的治疗点.
主要成果:
- 肥胖和过敏性喘之间的因果关系得到证实.
- 血蛋白TPST1,ROR1和DAPK1被确定为调解物.
- TPST1占中介效应的10%以上.
- SIGLEC12,BOLA1,HOMER2和TPST1显示出作为药物点的潜力.
结论:
- 根据BMI定义的肥胖症可能会通过TPST1,ROR1和DAPK1.1等血蛋白促进过敏性喘.
- TPST1和潜在的其他已识别的蛋白质可以作为肥胖个体过敏喘的治疗点.
- 需要进一步的研究来验证治疗潜力和阐明机制.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
233
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
233
Antiasthma Drugs: Leukotriene Modifiers
239
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
239
Allergic Drug Reactions
806
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
806
Asthma: Pathogenesis and Management
343
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
343
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Antiasthma Drugs: β2-Adrenoceptor Agonists
231
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
231


